PSAT1 Human

SKU:BHZ11000417
Catalog / Quick links
    Overview
    Click light‑blue chips for details
    Glutaminyl-Peptide Cyclotransferase Human Recombinant Phosphoserine aminotransferase (PSAT1) catalyzes the conversion of 3-phosphohydroxypyruvate into 3-phosphoserine which is dephosphorylated consequently by phosphoserine phosphatase to form L-serine. PSAT1 is probably a phosphoserine aminotransferase, based on similarity to proteins in mouse, rabbit, and Drosophila. PSAT1 is expressed at high levels in the brain, liver, kidney and pancreas, and very weakly expressed in the thymus, prostate, testis and colon. Defects in the PSAT1 gene are the cause of phosphoserine aminotransferase deficiency (PSATD). PSATD is distinguished biochemically by low plasma and cerebrospinal fluid concentrations of serine and glycine and clinically by intractable seizures, acquired microcephaly, hypertonia, and psychomotor retardation.
    Enzyme Type Transferase
    Species Human
    Form Liquid
    Expression System E. coli
    Purity 90.0%
    Gene Symbol PSAT1
    Source Escherichia Coli.
    Available Options
    5µg | 20µg | 1mg
    Options selector
    Catalog no. Size
    ENZ-209-5µg 5µg
    ENZ-209-20µg 20µg
    ENZ-209-1mg 1mg
    Field Specification
    Enzyme Type
    • Transferase
    Expression System
    • E. coli
    Form Liquid
    Formulation The PSAT1 solution (1mg/ml) contains 20mM Tris-HCl buffer (pH8.0), 20% glycerol and 1mM DTT.
    Product Type
    • Enzyme
    Purity 90.0%
    Source Escherichia Coli.
    Species Human
    Storage Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
    Target PSAT1

    Product Description

    Glutaminyl-Peptide Cyclotransferase Human Recombinant

    Overview

    Phosphoserine aminotransferase (PSAT1) catalyzes the conversion of 3-phosphohydroxypyruvate into 3-phosphoserine which is dephosphorylated consequently by phosphoserine phosphatase to form L-serine. PSAT1 is probably a phosphoserine aminotransferase, based on similarity to proteins in mouse, rabbit, and Drosophila. PSAT1 is expressed at high levels in the brain, liver, kidney and pancreas, and very weakly expressed in the thymus, prostate, testis and colon. Defects in the PSAT1 gene are the cause of phosphoserine aminotransferase deficiency (PSATD). PSATD is distinguished biochemically by low plasma and cerebrospinal fluid concentrations of serine and glycine and clinically by intractable seizures, acquired microcephaly, hypertonia, and psychomotor retardation.

    Specifications

    Purity Greater than 90.0% as determined by SDS-PAGE.
    Formulation The PSAT1 solution (1mg/ml) contains 20mM Tris-HCl buffer (pH8.0), 20% glycerol and 1mM DTT.
    Storage Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
    Expression System Escherichia Coli.

    Get a Quote

    Please use this form for bulk quantity requests or customized products.

    Contact Information

    Product Information

    Supplier Ads Slides show

    Add dynamic ads with slider